Research activities in Tissue Engineering and Regenerative Medicine (TERM) have been focusing on providing enabling technologies for regenerative medicine, including industrial scale cell/tissue culture in vitro, implantable biomaterials and processing, bio-manufacture of cellular therapeutics, and supply chain of living cells and tissues. We closely collaborate with clinicians in neural stem cell therapy, skin care and chronic wound healing, and orthopaedics.
In bio-design and bioprocessing, a particular interest is to develop platform technologies for molecular diagnostics. Working with colleagues in the Department of Engineering and the Oxford Suzhou Centre for Advanced Research, we have developed the third generation of loop mediated isothermal amplification technology (OxLAMP ® ) that is successfully used for rapid detection of Covid-19. The technology had been developed to detect other infectious diseases and cancers for point of care tests.